Related references
Note: Only part of the references are listed.Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research
Prakriti Gaba et al.
NATURE REVIEWS CARDIOLOGY (2023)
Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease
Susu Jin et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)
Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway
Yixuan Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
Saerok Shim et al.
FRONTIERS IN IMMUNOLOGY (2022)
Clinical and genetic determinants of the fatty liver-coagulation balance interplay in individuals with metabolic dysfunction
Luca Valenti et al.
JHEP REPORTS (2022)
Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19
Ching Chee Law et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Hypertension in NAFLD: An uncontrolled burden
Philipp Kasper et al.
JOURNAL OF HEPATOLOGY (2021)
Placenta-derived IL-32β activates neutrophils to promote preeclampsia development
Dan Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
IL32: The multifaceted and unconventional cytokine
Anuradha Gautam et al.
HUMAN IMMUNOLOGY (2021)
Association between interleukin-32 gene polymorphism and susceptibility to preeclampsia Running Head: Association of IL-32 and preeclampsia
Fatemeh Mazlum et al.
HYPERTENSION IN PREGNANCY (2021)
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou et al.
NATURE REVIEWS CARDIOLOGY (2021)
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update
Luca Valenti et al.
HEPATOLOGY COMMUNICATIONS (2021)
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
Guido Alessandro Baselli et al.
GUT (2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension
Fernando Elijovich et al.
CURRENT HYPERTENSION REPORTS (2020)
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Role of immune cells in hypertension
Antoine Caillon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Raul D. Santos et al.
ATHEROSCLEROSIS (2019)
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling
Siyang Wen et al.
CANCER LETTERS (2019)
Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction
Elena Y. Senchenkova et al.
HYPERTENSION (2019)
Interleukin-32 increases in coronary arteries and plasma from patients with coronary artery disease
Zicong Yang et al.
CLINICA CHIMICA ACTA (2019)
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
Nassim Dali-Youcef et al.
HEPATOLOGY COMMUNICATIONS (2019)
The immunology of hypertension
Allison E. Norlander et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?
Dimitrios Oikonomou et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo et al.
JOURNAL OF HEPATOLOGY (2018)
Intracellular interleukin-32 gamma mediates antiviral activity of cytokines against hepatitis B virus
Doo Hyun Kim et al.
NATURE COMMUNICATIONS (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension
Bryan Williams et al.
JOURNAL OF HYPERTENSION (2018)
Association between inflammation and systolic blood pressure in RA compared to patients without RA
Zhi Yu et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Association betweenMRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease
Roberto Lorbeer et al.
JOURNAL OF HYPERTENSION (2017)
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
Muhammad Zahoor et al.
BLOOD ADVANCES (2017)
Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission
Yui Shimizu et al.
MODERN RHEUMATOLOGY (2016)
Liver fat accumulation is associated with circulating PCSK9
Massimiliano Ruscica et al.
ANNALS OF MEDICINE (2016)
IL-32 Promotes Angiogenesis
Claudia A. Nold-Petry et al.
JOURNAL OF IMMUNOLOGY (2014)
TLR-mediated Induction of Proinflammatory Cytokine IL-32 in Corneal Epithelium
Lili Zhang et al.
CURRENT EYE RESEARCH (2013)
IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models
Young-Eun Park et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein
Haruki Hasegawa et al.
CYTOKINE (2011)
Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase
Alejandro Lopez-Suarez et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Under pressure: the search for the essential mechanisms of hypertension
Thomas M. Coffman
NATURE MEDICINE (2011)
Molecular characterization of IL-32 in human endothelial cells
Hanako Kobayashi et al.
CYTOKINE (2009)
Identification of the most active interleukin-32 isoform
Ji-Da Choi et al.
IMMUNOLOGY (2009)
IL-32-dependent effects of IL-1β on endothelial cell functions
Claudia A. Nold-Petry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adherence to Mediterranean diet and health status: meta-analysis
Francesco Sofi et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Involvement of IL-32 in activation-induced cell death in T cells
C Goda et al.
INTERNATIONAL IMMUNOLOGY (2006)
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
M Ferrario et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
Blood pressure and inflammation in apparently healthy men
CU Chae et al.
HYPERTENSION (2001)
Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy
T Ohtsuka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
